Skip to main content
. 2011 Aug 29;118(16):4394–4400. doi: 10.1182/blood-2011-03-344051

Table 1.

Patient characteristics

Sex ratio (female/male) 1.35 (23/17)
Age, y* 53.5 ± 23.1
Disease duration, mo* 33 ± 56
Platelet count at diagnosis, ×109/L* 19 ± 18.8
Number of treatments* 3.7 ± 2.5
Treatments
    Number of patients (%)
        Steroids 37 (92.5%)
        Rituximab 19 (47.5%)
        IVIg 19 (47.5%)
        Dapsone 19 (47.5%)
        Splenectomy 14 (35%)
        Danazol 3 (7.5%)
        Other 7 (17.5%)
*

Mean ± SD.